Post-fibrinolysis complication as embolic release of unknown intracavitary thrombus
DOI:
https://doi.org/10.32818/reccmi.a3n3a2Keywords:
mobile cardiac thrombus, thrombolysis, multiple ictusAbstract
Fibrinolytic therapy is the mainstay of the treatment of acute ischemic stroke. New embolic strokes as a complication of fibrinolytic treatment are described in a few cases in literature. It is believed that it could be due to the disintegration of a preexisting intracardiac thrombus. We present the case of a 63-year-old patient admitted for ischemic stroke of the left middle cerebral artery who undergoes fibrinolysis, after that she suffered multiple infarctions in different vascular territories, as consequence of a release of fragments of an intraventricular not-know thrombus. Early neurological deterioration after thrombolysis, with association of clinical signs corresponding to another vascular territory (different from the initially affected one), we should think about this entity.
Downloads
Metrics
References
Powers WJ, Derdeyn CP, Biller J, Coffey CS, Hoh BL, Jauch EC, et al. 2015 American Heart Association/American Stroke Association Focused Update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: a guideline for healthcare professionals from the American Heart Association/American Stroke Asso- ciation. Stroke. 2015; 46: 3020-3035. doi: https://doi.org/10.1161/STR.0000000000000074.
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018 Mar; 49(3): e46-e110. doi: https://doi.org/10.1161/STR.0000000000000158.
Kamal H, Mowla A, Farooq S, Shirani P. Recurrent ischemic stroke can happen in stroke patients very early after intravenous thrombolysis. J Neurol Sci. 2015; 358: 496-497. doi: https://doi.org/10.1016/j.jns.2015.09.020.
Tanaka K, Ohara T, Ishigami A, Ikeda Y, Matsushige T, Satow T, et al. Fatal multiple systemic emboli after intravenous thrombolysis for cardioembolic stroke. J Stroke Cerebrovasc Dis. 2014 Feb; 23(2): 395-397. doi: https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.03.007.
Yalcin-Cakmakli G, Akpinar E, Topcuoglu MA, Dalkara T. Right internal carotid artery occlusion during intravenous thrombolysis for left middle cerebral artery occlusion. J Stroke Cerebrovasc Dis. 2009 Jan; 18(1): 74-77. doi: https://doi.org/10.1016/j.jstrokecerebrovasdis.2008.08.007.
Oberreuter G, Silva N, Caba S, Morales M, Nieto E, Guevara C. Accidente cerebrovascular isquémico en pacientes con trombo intracavitario: experiencia con tratamientos distintos en fase aguda. Rev Med Chil. 2014 Sep; 142(9): 1200-1204. doi: https://doi.org/10.4067/S0034-98872014000900015.
Kobayashi M, Tanaka R, Yamashiro K, Ueno Y, Kato E, Miura S, et al. Preexisting mobile cardiac thrombus and the risk of early recurrent embolism after intravenous thrombolysis: a case report. J Stroke Cerebrovasc Dis. 2015 Jun; 24(6): e161-3. doi: https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.03.001.
Safouris A, Kargiotis O, Magoufis G, Katsanos AH, Stamboulis E, Tsivgoulis G. Early neurological deterioration during alteplase infusion for acute ischemic stroke: an uncommon complication of intravenous thrombolysis. Neurologist. 2017 May; 22(3): 90-91. doi: https://doi.org/10.1097/NRL.0000000000000118.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 Juncal Sánchez-Arguiano, Maite Arlabán-Carpintero, Enrique Chicote-Álvarez, María Ángeles Ballesteros-Sanz, Manuel Gayol-Fernández
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Permite compartir, copiar y redistribuir el material en cualquier medio o formato, bajo los siguientes términos:
Reconocimiento: debe otorgar el crédito correspondiente, proporcionar un enlace a la licencia e indicar si se realizaron cambios. Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o su uso.
No comercial: no puede utilizar el material con fines comerciales.
No Derivados: si remezcla, transforma o construye sobre el material, no puede distribuir el material modificado.
Sin restricciones adicionales: no puede aplicar términos legales o medidas tecnológicas que restrinjan legalmente a otros de hacer cualquier cosa que permita la licencia.
